Pacific Biosciences Of California (PACB) Accumulated Expenses (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Accumulated Expenses of $33.9 million for Q1 2026, up 15.57% year-over-year from $29.3 million in Q1 2025, and up 0.77% quarter-over-quarter from $33.6 million in Q4 2025.
Pacific Biosciences Of California (PACB) Accumulated Expenses (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Accumulated Expenses history runs 17 years deep, the most recent figure standing at $33.9 million for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 15.57% year-over-year to $33.9 million; the TTM figure through Mar 2026 stood at $33.9 million (up 15.57% YoY), while the FY2025 annual figure was $33.6 million, up 48.91% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $33.9 million, up from $33.6 million in the prior quarter.
- The five-year high for Accumulated Expenses was $45.7 million in Q4 2023, with the low at $19.2 million in Q3 2024.
- The 5-year median for Accumulated Expenses is $26.5 million (2025), against an average of $27.5 million.
- The sharpest annual moves came in 2024 and 2025: Accumulated Expenses slumped 50.57% in 2024, then jumped 52.07% in 2025.
- Pacific Biosciences Of California's Accumulated Expenses stood at $32.6 million in 2022, then surged by 40.23% to $45.7 million in 2023, then plunged by 50.57% to $22.6 million in 2024, then surged by 48.91% to $33.6 million in 2025, then gained by 0.77% to $33.9 million in 2026.
- Business Quant data shows PACB's Accumulated Expenses at $33.9 million in Q1 2026, $33.6 million in Q4 2025, and $29.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 419.38 Mn | 182.51 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.32 Mn |
| Mar 31, 2026 | 33.90 Mn |
| Dec 31, 2025 | 33.65 Mn |
| Sep 30, 2025 | 29.17 Mn |
| Jun 30, 2025 | 26.54 Mn |
| Mar 31, 2025 | 29.34 Mn |
| Dec 31, 2024 | 22.60 Mn |
| Sep 30, 2024 | 19.18 Mn |
| Jun 30, 2024 | 22.46 Mn |
| Mar 31, 2024 | 21.99 Mn |
| Dec 31, 2023 | 45.71 Mn |
| Sep 30, 2023 | 34.66 Mn |
| Jun 30, 2023 | 27.01 Mn |
| Mar 31, 2023 | 19.38 Mn |
| Dec 31, 2022 | 32.60 Mn |
| Sep 30, 2022 | 24.89 Mn |
| Jun 30, 2022 | 25.17 Mn |
| Mar 31, 2022 | 19.49 Mn |
| Dec 31, 2021 | 36.26 Mn |
| Jun 30, 2021 | 22.91 Mn |